These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6144765)

  • 41. Increased plasma binding of quinidine after surgery: a preliminary report.
    Fremstad D; Bergerud K; Haffner JF; Lunde PK
    Eur J Clin Pharmacol; 1976; 10(6):441-4. PubMed ID: 63371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
    Brunner F; Müller WE
    J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.
    Belpaire FM; Bogaert MG; Rosseneu M
    Eur J Clin Pharmacol; 1982; 22(3):253-6. PubMed ID: 6125395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.
    Sager G; Jaeger R; Little C
    Br J Clin Pharmacol; 1989 Feb; 27(2):229-34. PubMed ID: 2713217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy.
    Krauer B; Nau H; Dayer P; Bischof P; Anner R
    Br J Obstet Gynaecol; 1986 Apr; 93(4):322-8. PubMed ID: 3964607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
    Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
    J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum protein binding of drugs and bilirubin in newborn infants and their mothers.
    Hamar C; Levy G
    Clin Pharmacol Ther; 1980 Jul; 28(1):58-63. PubMed ID: 7389254
    [No Abstract]   [Full Text] [Related]  

  • 48. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein binding of nifedipine.
    Otto J; Lesko LJ
    J Pharm Pharmacol; 1986 May; 38(5):399-400. PubMed ID: 2872322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug protein binding and the nephrotic syndrome.
    Gugler R; Azarnoff DL
    Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereoselective binding of propranolol in the elderly.
    Colangelo P; Chandler M; Blouin R; McNamara P
    Br J Clin Pharmacol; 1989 Apr; 27(4):519-22. PubMed ID: 2719906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences between blacks and whites in plasma protein binding of drugs.
    Johnson JA; Livingston TN
    Eur J Clin Pharmacol; 1997; 51(6):485-8. PubMed ID: 9112064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats.
    Kawase A; Ikuta H; Uno S; Yamamoto K; Akitsu N; Nagao T; Iwaki M
    Xenobiotica; 2013 Mar; 43(3):246-52. PubMed ID: 22867272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
    Dasgupta A; Timmerman TG
    Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gallopamil binding to human serum proteins.
    Rutledge DR; Pieper JA
    Eur J Clin Pharmacol; 1987; 33(4):375-80. PubMed ID: 3443143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans.
    Teirlynck O; Belpaire FM; Andreasen F
    Eur J Clin Pharmacol; 1982; 21(5):427-31. PubMed ID: 7075647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
    MacKichan JJ; Zola EM
    Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug binding to plasma proteins.
    Paxton JW
    N Z Med J; 1985 Apr; 98(776):245-8. PubMed ID: 3857503
    [No Abstract]   [Full Text] [Related]  

  • 60. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
    Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
    Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.